EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
View Top Employees from EpiBone, Inc.Website | http://www.epibone.com |
Revenue | $10 million |
Funding | $560000 |
Employees | 29 (29 on RocketReach) |
Founded | 2013 |
Address | 760 Parkside Ave Ste 322, Brooklyn, New York 11226, US |
Phone | (212) 653-8828 |
Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Construction, Real Estate, Health Care, Medical |
Web Rank | 15 Million |
Keywords | Epibone, Inc., Epi Bone, Epibone |
Competitors | DiscGenics, Juventas Therapeutics, Inc., NOVADIP Biosciences S.A., Regeneus Ltd, VIDEREGEN LIMITED |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular EpiBone, Inc. employee's phone or email?
The EpiBone, Inc. annual revenue was $10 million in 2024.
Nina Tandon is the CEO of EpiBone, Inc..
29 people are employed at EpiBone, Inc..
EpiBone, Inc. is based in Brooklyn, New York.
The NAICS codes for EpiBone, Inc. are [54, 541713, 54171, 541, 5417].
The SIC codes for EpiBone, Inc. are [873, 87].